Literature DB >> 19644581

Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis.

Zuyi Yuan1, Keisuke Shioji, Chiharu Kishimoto.   

Abstract

Animal models of myocarditis are of great value for studying the pathophysiology of the disease. To clarify the key factors for determining the severity of myocarditis, we analyzed immunohistological surface markers of myocardial infiltrating cells in various animal models, and the relationship between myocardiogenic antigens and abnormal behaviours of infiltrating cells was discussed. Myocarditis was induced in mice and rats by cardiotropic viruses and by porcine cardiac myosin. Animals were sacrificed at the peak of their disease. Pathological examinations were performed, and the severity of the lesions was scored semiquantitatively. There were striking differences in the severity of viral and autoimmune giant cell myocarditis among different animal models. However, the majority of myocardial infiltrating cells were comprised of macrophages and CD4+ T cells. Different immunological behaviours of myocardial infiltrating cells were demonstrated in these models of myocarditis. However, the development of severe myocardial lesions may depend on the macrophage-CD4 cell lineage in these animal models.

Entities:  

Keywords:  Animal model; Giant cell myocarditis; Viral myocarditis

Year:  2003        PMID: 19644581      PMCID: PMC2716193     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  15 in total

Review 1.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.

Authors:  C Kawai
Journal:  Circulation       Date:  1999-03-02       Impact factor: 29.690

2.  Generation of humanized mice susceptible to peptide-induced inflammatory heart disease.

Authors:  K Bachmaier; N Neu; R S Yeung; T W Mak; P Liu; J M Penninger
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

3.  Autoimmune myocarditis does not require B cells for antigen presentation.

Authors:  S Malkiel; S Factor; B Diamond
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

4.  A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction.

Authors:  M Kodama; Y Matsumoto; M Fujiwara; F Masani; T Izumi; A Shibata
Journal:  Clin Immunol Immunopathol       Date:  1990-11

5.  Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats.

Authors:  K Shioji; C Kishimoto; H Nakamura; S Toyokuni; Y Nakayama; J Yodoi; S Sasayama
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

6.  Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease.

Authors:  N Neu; B Ploier; C Ofner
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

7.  Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics.

Authors:  S Hirono; M O Islam; M Nakazawa; Y Yoshida; M Kodama; A Shibata; T Izumi; S Imai
Journal:  Circ Res       Date:  1997-01       Impact factor: 17.367

8.  Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection.

Authors:  M A Opavsky; J Penninger; K Aitken; W H Wen; F Dawood; T Mak; P Liu
Journal:  Circ Res       Date:  1999-09-17       Impact factor: 17.367

9.  Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.

Authors:  C Kishimoto; Y Kuroki; Y Hiraoka; H Ochiai; M Kurokawa; S Sasayama
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

10.  Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice.

Authors:  Y Hiraoka; C Kishimoto; H Takada; M Kurokawa; H Ochiai; K Shiraki; S Sasayama
Journal:  Cardiovasc Res       Date:  1993-06       Impact factor: 10.787

View more
  4 in total

1.  Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.

Authors:  Alexandre Reuben; Mariana Petaccia de Macedo; Jennifer McQuade; Aron Joon; Zhiyong Ren; Tiffany Calderone; Brandy Conner; Khalida Wani; Zachary A Cooper; Hussein Tawbi; Michael T Tetzlaff; Robert F Padera; Jean-Bernard Durand; Alexander J Lazar; Jennifer A Wargo; Michael A Davies
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

Review 2.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

3.  Nucleotide differences of coxsackievirus B3 and chronic myocarditis.

Authors:  Chiharu Kishimoto; Nami Takamatsu; Hiroshi Ochiai; Kagemasa Kuribayashi
Journal:  Heart Vessels       Date:  2014-02-04       Impact factor: 2.037

4.  Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors.

Authors:  Marco Merlo; Enrico Ammirati; Piero Gentile; Jessica Artico; Antonio Cannatà; Gherardo Finocchiaro; Giulia Barbati; Paola Sormani; Marisa Varrenti; Andrea Perkan; Enrico Fabris; Aneta Aleksova; Rossana Bussani; Duccio Petrella; Manlio Cipriani; Claudia Raineri; Maria Frigerio; Gianfranco Sinagra
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.